Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis (EoE)
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
The company plans to expand its portfolio in regulated markets aggressively
RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
The rates for over 400 procedures were revised
The transaction is anticipated to close in the first quarter of 2022
A total of 8308 stores are open across India and medicines are priced at affordable rates
The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme
Subscribe To Our Newsletter & Stay Updated
